Skip to main content
. 2017 Mar 29;18(4):730. doi: 10.3390/ijms18040730

Figure 2.

Figure 2

Kaplan–Meier analysis of the OS of 39 Stage IV pancreatic cancer patients receiving standard palliative chemotherapy with gemcitabine- or 5-fluoracile-based regimens, with an NLR higher or lower than 5.